glp 1 and resting heart rate Differential effects of glucagon-like peptide-1 receptor agonists on | Cardiovascular Diabetology Will Ahmed | New Whoop

However, cardiovascular safety trials in type 2 diabetes patients, the majority presenting cardiovascular disease and excess weight, showed that GLP-1 receptor agonists were indeed capable of decreasing cardiovascular risk

While most patients return to their baseline state, individual responses vary, and some may experience more pronounced hunger or cravings during the adjustment period

Common side effects: Nausea, constipation, diarrhea, or mild stomach upsetusually temporary and manageable

But since this is a common practice among telehealth outfits offering similar treatments, its hard to hold it against Maximus specifically